Tharimmune Inc. (THAR NASDAQ) stock market data APIs
$2.4064
0.05(2.1%)
as of December 5, 2025
Try our APIs with
free plan!
Tharimmune Inc. Financial Data Overview
Price chart is built with
Anychart
Tharimmune, Inc., a clinical-stage biotechnology company, engages in the development of therapeutic candidates for immunology and inflammation conditions in the United States. It is involved in the development of TH104 for the proposed indication of temporary prophylaxis of respiratory and/or nervous system depression in military personnel and chemical incident responders entering and area contaminated with opioids, as well as is in phase 2 study in patients with chronic pruritus in primary biliary cholangitis. The company also engages in the development of TH023 to treat autoimmune indications; and HS1940, a bispecific biologic against PD-1 and vascular endothelial growth receptor antibody that targets both receptors. It has a research collaboration and product license agreement with Minotaur Therapeutics, Inc. for the development of proprietary targeted biologics. The company was formerly known as Hillstream BioPharma, Inc. and changed its name to Tharimmune, Inc. in September 2023. Tharimmune, Inc. was incorporated in 2017 and is based in Red Bank, New Jersey.
Prev. Close
2.4064
Open
2.4531
High
2.4787
Low
2.3467
52 wk Range
0.952-9.08
Market Cap
83 757 K
Shares Outstanding
35 045 K
EPS
-0.64
Beta
1.452
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Tharimmune Inc. (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Tharimmune Inc. data using free add-ons & libraries
Get Tharimmune Inc. Fundamental Data
Tharimmune Inc. Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-14
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Tharimmune Inc. News
New
Crypto Treasury Companies Are Chasing Obscure Tokens—And That's Raising Red Flags About Market Volatility
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. As Bitcoin’s shine dulls and market saturation squeezes returns, a new breed of publicly traded ...
New Crypto Deals Put Retail at Risk After $17 Billion Wipeout
(Bloomberg) -- Executives are turning to a novel structure to fund crypto accumulation vehicles as investor appetite thins. They’re called in-kind contributions, and they now account for a growing ...
Tharimmune Stock Gains 30%, on $540M Capital Raise to Build Canton Coin Treasury Strategy
Nasdaq-listed Tharimmune (THAR) has raised about $540 million in a private placement led by DRW and Liberty City Ventures, as the biotech firm pivots toward a digital asset treasury (DAT) strategy cen...
Tharimmune Announces Upcoming Conference Presentations Highlighting Lead Asset TH104, A New Formulation Against Ultrapotent Opioids and Fentanyl
RED BANK, N.J., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Tharimmune, Inc. (Nasdaq: THAR), a clinical-stage biotechnology company dedicated to developing innovative therapeutic candidates for inflammation,...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
